Arvinas Stock Fundamentals
| ARVN Stock | USD 8.43 0.12 1.40% |
Arvinas fundamentals help investors to digest information that contributes to Arvinas' financial success or failures. It also enables traders to predict the movement of Arvinas Stock. The fundamental analysis module provides a way to measure Arvinas' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Arvinas stock.
Arvinas |
Arvinas Company Current Valuation Analysis
Arvinas' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Arvinas Current Valuation | (408.69 M) |
Most of Arvinas' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Arvinas is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Arvinas has a Current Valuation of (408.69 Million). This is 102.85% lower than that of the Pharmaceuticals sector and 108.8% lower than that of the Health Care industry. The current valuation for all United States stocks is 102.46% higher than that of the company.
Arvinas Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Arvinas's current stock value. Our valuation model uses many indicators to compare Arvinas value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Arvinas competition to find correlations between indicators driving Arvinas's intrinsic value. More Info.Arvinas is rated third in return on equity category among its peers. It is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Arvinas' earnings, one of the primary drivers of an investment's value.Arvinas Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Arvinas' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Arvinas could also be used in its relative valuation, which is a method of valuing Arvinas by comparing valuation metrics of similar companies.Arvinas is currently under evaluation in current valuation category among its peers.
Arvinas Fundamentals
| Return On Equity | -0.33 | ||||
| Return On Asset | -0.13 | ||||
| Profit Margin | (0.76) % | ||||
| Operating Margin | (0.98) % | ||||
| Current Valuation | (408.69 M) | ||||
| Shares Outstanding | 68.77 M | ||||
| Shares Owned By Insiders | 7.62 % | ||||
| Shares Owned By Institutions | 92.38 % | ||||
| Number Of Shares Shorted | 11.54 M | ||||
| Price To Earning | (0.45) X | ||||
| Price To Book | 1.11 X | ||||
| Price To Sales | 2.23 X | ||||
| Revenue | 263.4 M | ||||
| Gross Profit | 263.4 M | ||||
| EBITDA | (250.2 M) | ||||
| Net Income | (198.9 M) | ||||
| Cash And Equivalents | 1.27 B | ||||
| Cash Per Share | 23.87 X | ||||
| Total Debt | 9.1 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 5.33 X | ||||
| Book Value Per Share | 8.16 X | ||||
| Cash Flow From Operations | (259.3 M) | ||||
| Short Ratio | 10.62 X | ||||
| Earnings Per Share | (2.77) X | ||||
| Price To Earnings To Growth | 0.28 X | ||||
| Target Price | 45.26 | ||||
| Number Of Employees | 430 | ||||
| Beta | 1.96 | ||||
| Market Capitalization | 588 M | ||||
| Total Asset | 1.09 B | ||||
| Retained Earnings | (1.53 B) | ||||
| Working Capital | 837.5 M | ||||
| Current Asset | 80.17 M | ||||
| Current Liabilities | 15.89 M | ||||
| Net Asset | 1.09 B |
About Arvinas Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Arvinas's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Arvinas using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Arvinas based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Arvinas, Inc. was founded in 2013 and is based in New Haven, Connecticut. Arvinas operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 280 people.
Pair Trading with Arvinas
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Arvinas position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arvinas will appreciate offsetting losses from the drop in the long position's value.Moving against Arvinas Stock
| 0.55 | KRYS | Krystal Biotech | PairCorr |
| 0.47 | DXR | Daxor | PairCorr |
| 0.39 | PEPG | PepGen | PairCorr |
| 0.36 | VRCA | Verrica Pharmaceuticals | PairCorr |
The ability to find closely correlated positions to Arvinas could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Arvinas when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Arvinas - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Arvinas to buy it.
The correlation of Arvinas is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Arvinas moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Arvinas moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Arvinas can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Arvinas Piotroski F Score and Arvinas Altman Z Score analysis. To learn how to invest in Arvinas Stock, please use our How to Invest in Arvinas guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arvinas. If investors know Arvinas will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arvinas listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Arvinas is measured differently than its book value, which is the value of Arvinas that is recorded on the company's balance sheet. Investors also form their own opinion of Arvinas' value that differs from its market value or its book value, called intrinsic value, which is Arvinas' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arvinas' market value can be influenced by many factors that don't directly affect Arvinas' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arvinas' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arvinas is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arvinas' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.